Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation

Recently, 2 small molecule kinase inhibitors (TKIs), targeting epidermal growth factor receptor (EGFR), have proven effective in the treatment of non-small cell lung cancer. However, it is unknown whether the EGFR double activating mutation of L858R in exon 21 and the in-frame deletion in exon 19 is...

Descripción completa

Detalles Bibliográficos
Autores principales: Masago, Katsuhiro, Togashi, Yosuke, Fukudo, Masahide, Terada, Tomohiro, Irisa, Kaoru, Sakamori, Yuichi, Fujita, Shiro, Kim, Young Hak, Mio, Tadashi, Inui, Ken-ichi, Mishima, Michiaki
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: April 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919984/
https://www.ncbi.nlm.nih.gov/pubmed/20740181
http://dx.doi.org/10.1159/000310830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919984/
https://www.ncbi.nlm.nih.gov/pubmed/20740181
http://dx.doi.org/10.1159/000310830

Ejemplares similares